Search
BIO 2026: Texas based Nanoscope Therapeutics is using optogenetics, or light to turn cells on or off, to try to restore vision for retinal conditions
CEO Sulagna Bhattacharya describes the science behind this, which is gene agnostic, and the work the company is going to develop it and seek approvals both in Japan and the United States.
Jun 26
.png){kind=logo}